The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

MEDraysintell releases its new Early Stage Radiopharmaceuticals Report

New system overcomes challenges of nanotheranostics

Bruker acquires preclinical and molecular imaging research software provider PMOD Technologies

ASRT opposes NRC proposed changes to radiopharmaceutical training and experience standards

Nuclear stress test helps identify heart attack risk in people with diabetes

New combination therapy established as safe and effective for prostate cancer

Standard defines measurement methods for performance parameters of SPECT scanners

Blue Earth Diagnostics announces results from investigational clinical study of safety and effectiveness of 18F-Fluciclovine PET

Scientists discover new method for developing tracers used for medical imaging

Radiology's role in determining the impact of Amyloid PET imaging on real-world Alzheimer's disease and dementia care

The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system

Press releases may be edited for formatting or style
Tel Aviv and Utrecht, July 9 2019 - Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a VECTor PET/SPECT/CT to help bridge the gap between academic discoveries and new products that benefit patients. The system will be installed at Sackler Cellular and Molecular Imaging Center (SCMIC), which will serve as the core imaging facility.

The head of the center is Tel Aviv University Cancer Biology Research Center chairperson Prof. Dan Peer. Prof. Peer explains that the center's goal is to strengthen the Israeli drug industry by accelerating bench discoveries into the clinic. “Due to the high resolution of its multiple modalities, MILabs VECTor is expected to be great tool since its visual acuity for imaging animals is similar to the one achievable in the clinic with human patients”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Prof. Ilan Tsarfaty, Director of Sackler Cellular and Molecular Imaging Center (SCMIC) adds:’ We are excited about the addition of this innovative multimodal in vivo translational imaging system to our core imaging facility.”

According to Prof. Beekman, CEO/CSO MILabs B.V. “While the visual acuity of our PET/SPECT and CT modalities are indeed outstanding, we believe that the one-to-one translation of PET and SPECT results by simultaneous imaging of co-injected tracers will significantly contribute to a quick translation of in vivo research results to clinical trials”


About TAU Translational Medicine Center:
The center is modeled after a revolutionary approach to drug research first adopted by universities such as Harvard, Stanford and New York University. It replaces the traditional drug development model whereby only pharma/VC companies pay for the proof-of-concept and early clinical trials of drug candidates. For more info: http://spark-telaviv.tau.ac.il/2018/04/22/tau-sets-up-translational-medical-research-center/


About MILabs B.V.
This Dutch company has a history of providing innovations to expand the applications of in-vivo imaging using PET, SPECT, Optical and X-ray CT. Available in any combination or as stand-alone systems, MILabs preclinical imaging modalities are globally recognized for being able to deliver the highest quality small-animal molecular, functional and anatomical images.

For more information, visit: www.milabs.com or contact MILabs at info@milabs.com

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment